ERC-AG-LS4
ERC-AG-LS4
Programme: H2020
66 projects · €161,684,626 total EU contribution (project-level) · 53 participating organizations · 14 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€161,684,626
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (12)
- Germany (8)
- France (5)
- Italy (5)
- CH (4)
- Spain (4)
- SE (3)
- AT (2)
- FI (2)
- IL (2)
- Netherlands (2)
- DK (1)
- EL (1)
- LB (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- KI5 projects · SE
- EPFL4 projects · CH
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4 projects · UK
- HELSINGIN YLIOPISTO3 projects · FI
- INSERM3 projects · FR
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE3 projects · UK
- ETH Zürich2 projects · CH
- IRB BARCELONA - CERCA2 projects · ES
- FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III2 projects · ES
- .2 projects · IT
- IMBA2 projects · AT
- ISTITUTO EUROPEO DI ONCOLOGIA SRL2 projects · IT
Projects
Page 6 of 7
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
KRAB/KAP1-mediated gene regulation in mammalian physiology and human diseases KRABNKAP · 268721 | FP7 | €2,499,996 | €2,499,996 | Details |
p53 control of epithelial homeostasis PICHO · 294390 | FP7 | €2,500,000 | €2,500,000 | Details |
OVErcoming Resistance to anti-HER2 therapy OVER-HER2 · 250244 | FP7 | €1,666,700 | €1,666,700 | Details |
Signal integration and rewiring during tumor development P38CANCER · 294665 | FP7 | €2,497,800 | €2,497,800 | Details |
Molecular by-pass therapy for mitochondrial dysfunction MITO BY-PASS · 232738 | FP7 | €2,436,000 | €2,436,000 | Details |
General and targeted approaches to unravel the molecular causes of type 2 diabetes GENE TARGET T2D · 269045 | FP7 | €2,499,480 | €2,499,480 | Details |
THE ENDOCYTIC AND CYTOSKELETAL MATRIX IN THE PLASTICITY OF TUMOR CELL INVASION AND MIGRATION THE METAENDOMATRIX · 268836 | FP7 | €2,232,200 | €2,232,200 | Details |
Longevity and aging associated genes that control self-renewal and function of adult stem cells during aging STEMCELLGERONTOGENES · 323136 | FP7 | €2,498,400 | €2,498,400 | Details |
Ras Genes in Health and Disease RAS AHEAD · 250297 | FP7 | €2,496,192 | €2,496,192 | Details |
Host-microbiota interactions across the gut immune system: lessons from early onset inflammatory bowel diseases and from gnotobiotic mice IMMUNOBIOTA · 339407 | FP7 | €2,499,551 | €2,499,551 | Details |